Related Experiment Videos
Ceftriaxone in treatment of serious infections. Septicemia
1University of Florida, Jacksonville.
Insights
Ceftriaxone is a safe and effective antibiotic for treating serious bacterial infections like septicemia and bacteremia in all ages. Its long half-life allows for convenient dosing, reducing treatment frequency for adults and children.
Area of Science:
- Pharmacology
- Infectious Diseases
- Clinical Therapeutics
Background:
- Ceftriaxone is a third-generation cephalosporin antibiotic.
- Serious infections involving bacteremia require effective antimicrobial therapy.
Purpose of the Study:
- To evaluate the safety and efficacy of ceftriaxone as a single agent for septicemia and bacteremia.
- To highlight the pharmacokinetic advantages of ceftriaxone.
Main Methods:
- Clinical use of ceftriaxone as monotherapy for serious infections.
- Pharmacokinetic analysis focusing on serum half-life.
Main Results:
- Ceftriaxone demonstrated safety and efficacy in treating septicemia and bacteremia in adults and children.
- The long serum half-life of ceftriaxone facilitates less frequent administration.
Conclusions:
- Ceftriaxone is a reliable monotherapy option for severe bacterial infections.
- The dosing convenience of ceftriaxone improves patient management.
Abstract:
Ceftriaxone is generally recognized as safe and effective when used as a single drug in the therapy of septicemia and other serious infections involving bacteremia in both adults and children. An advantage of ceftriaxone over other third-generation cephalosporins is its long serum half-life, which allows the drug to be given every 12 hours in children or less frequently in adults.